3863. Deputy Cormac Devlin asked the Minister for Health whether the Health Service Executive Medicines Management Programme or the National Clinical Programme for Respiratory has examined the extent to which reimbursement arrangements under the community drug schemes support the use of maintenance and reliever therapy as the preferred treatment for asthma in persons aged 12 years and over, as recommended in clinical guidelines; and if she will make a statement on the matter. [63197/26]

Summary

3863. Deputy Cormac Devlin asked the Minister for Health whether the Health Service Executive Medicines Management Programme or the National Clinical Programme for Respiratory has examined the extent to which reimbursement arrangements under the community drug schemes support the use of maintenance and reliever therapy as the preferred treatment for asthma in persons aged 12 years and over, as recommended in clinical guidelines; and if she will make a statement on the matter. [63197/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 September 2026

   Medicinal Products

   3863. Deputy Cormac Devlin asked the Minister for Health whether the Health Service Executive Medicines Management Programme or the National Clinical Programme for Respiratory has examined the extent to which reimbursement arrangements under the community drug schemes support the use of maintenance and reliever therapy as the preferred treatment for asthma in persons aged 12 years and over, as recommended in clinical guidelines; and if she will make a statement on the matter. [63197/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 7 September 2026

  ViewDownloadOpen at official source

Sponsors

• Cormac Devlin · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.